AIM ImmunoTech, Inc. (AIM)
0.8107
-0.03
(-3.91%)
USD |
NYAM |
Feb 12, 16:00
0.8107
0.00 (0.00%)
After-Hours: 20:00
AIM ImmunoTech EPS Diluted (Quarterly) : -1.567 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 1.432 |
| Agenus, Inc. | 1.944 |
| Curis, Inc. | -0.4929 |
| LadRx Corp. | -1.453 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.284M |
| Revenue (Quarterly) | 0.026M |
| Total Expenses (Quarterly) | 3.31M |
| Enterprise Value | 2.800M |
| Gross Profit Margin (Quarterly) | -369.2% |
| Profit Margin (Quarterly) | -12.63K% |
| Earnings Yield | -1.84K% |
| Normalized Earnings Yield | -1832.84 |